174 related articles for article (PubMed ID: 34473764)
1. Chronic presence of blood circulating anti-NMDAR1 autoantibodies impairs cognitive function in mice.
Yue W; Caldwell S; Risbrough V; Powell S; Zhou X
PLoS One; 2021; 16(9):e0256972. PubMed ID: 34473764
[TBL] [Abstract][Full Text] [Related]
2. Cognitive Impact by Blood Circulating Anti-NMDAR1 Autoantibodies.
Zhou X
J Psychiatr Brain Sci; 2021; 6():. PubMed ID: 34307898
[TBL] [Abstract][Full Text] [Related]
3. Uncoupling the widespread occurrence of anti-NMDAR1 autoantibodies from neuropsychiatric disease in a novel autoimmune model.
Pan H; Oliveira B; Saher G; Dere E; Tapken D; Mitjans M; Seidel J; Wesolowski J; Wakhloo D; Klein-Schmidt C; Ronnenberg A; Schwabe K; Trippe R; Mätz-Rensing K; Berghoff S; Al-Krinawe Y; Martens H; Begemann M; Stöcker W; Kaup FJ; Mischke R; Boretius S; Nave KA; Krauss JK; Hollmann M; Lühder F; Ehrenreich H
Mol Psychiatry; 2019 Oct; 24(10):1489-1501. PubMed ID: 29426955
[TBL] [Abstract][Full Text] [Related]
4. Preventive and Therapeutic Autoantibodies Protect against Neuronal Excitotoxicity.
Zhou X
J Psychiatr Brain Sci; 2023; 8(3):. PubMed ID: 37502631
[TBL] [Abstract][Full Text] [Related]
5. A Novel Simple ImmunoAssay for Quantification of Blood Anti-NMDAR1 Autoantibodies.
Vaughn M; Powell S; Risbrough V; Zhou X
bioRxiv; 2024 Apr; ():. PubMed ID: 38659751
[TBL] [Abstract][Full Text] [Related]
6. Autoantibodies against N-methyl-d-aspartate receptor 1 in health and disease.
Ehrenreich H
Curr Opin Neurol; 2018 Jun; 31(3):306-312. PubMed ID: 29474316
[TBL] [Abstract][Full Text] [Related]
7. Preexisting Serum Autoantibodies Against the NMDAR Subunit NR1 Modulate Evolution of Lesion Size in Acute Ischemic Stroke.
Zerche M; Weissenborn K; Ott C; Dere E; Asif AR; Worthmann H; Hassouna I; Rentzsch K; Tryc AB; Dahm L; Steiner J; Binder L; Wiltfang J; Sirén AL; Stöcker W; Ehrenreich H
Stroke; 2015 May; 46(5):1180-6. PubMed ID: 25765725
[TBL] [Abstract][Full Text] [Related]
8. Neuronal autoantibodies associated with cognitive impairment in melanoma patients.
Bartels F; Strönisch T; Farmer K; Rentzsch K; Kiecker F; Finke C
Ann Oncol; 2019 May; 30(5):823-829. PubMed ID: 30840061
[TBL] [Abstract][Full Text] [Related]
9. Autoantibodies against NMDA receptor 1 modify rather than cause encephalitis.
Wilke JBH; Hindermann M; Berghoff SA; Zihsler S; Arinrad S; Ronnenberg A; Barnkothe N; Steixner-Kumar AA; Röglin S; Stöcker W; Hollmann M; Nave KA; Lühder F; Ehrenreich H
Mol Psychiatry; 2021 Dec; 26(12):7746-7759. PubMed ID: 34331009
[TBL] [Abstract][Full Text] [Related]
10. All naturally occurring autoantibodies against the NMDA receptor subunit NR1 have pathogenic potential irrespective of epitope and immunoglobulin class.
Castillo-Gómez E; Oliveira B; Tapken D; Bertrand S; Klein-Schmidt C; Pan H; Zafeiriou P; Steiner J; Jurek B; Trippe R; Prüss H; Zimmermann WH; Bertrand D; Ehrenreich H; Hollmann M
Mol Psychiatry; 2017 Dec; 22(12):1776-1784. PubMed ID: 27502473
[TBL] [Abstract][Full Text] [Related]
11. The brain as immunoprecipitator of serum autoantibodies against N-Methyl-D-aspartate receptor subunit NR1.
Castillo-Gomez E; Kästner A; Steiner J; Schneider A; Hettling B; Poggi G; Ostehr K; Uhr M; Asif AR; Matzke M; Schmidt U; Pfander V; Hammer C; Schulz TF; Binder L; Stöcker W; Weber F; Ehrenreich H
Ann Neurol; 2016 Jan; 79(1):144-51. PubMed ID: 26505629
[TBL] [Abstract][Full Text] [Related]
12. Apolipoprotein E4 carrier status plus circulating anti-NMDAR1 autoantibodies: association with schizoaffective disorder.
Hammer C; Zerche M; Schneider A; Begemann M; Nave KA; Ehrenreich H
Mol Psychiatry; 2014 Oct; 19(10):1054-6. PubMed ID: 24888362
[No Abstract] [Full Text] [Related]
13. Multiple inducers and novel roles of autoantibodies against the obligatory NMDAR subunit NR1: a translational study from chronic life stress to brain injury.
Pan H; Steixner-Kumar AA; Seelbach A; Deutsch N; Ronnenberg A; Tapken D; von Ahsen N; Mitjans M; Worthmann H; Trippe R; Klein-Schmidt C; Schopf N; Rentzsch K; Begemann M; Wienands J; Stöcker W; Weissenborn K; Hollmann M; Nave KA; Lühder F; Ehrenreich H
Mol Psychiatry; 2021 Jun; 26(6):2471-2482. PubMed ID: 32089545
[TBL] [Abstract][Full Text] [Related]
14. Serum Anti-NMDA (N-Methyl-D-Aspartate)-Receptor Antibodies and Long-Term Clinical Outcome After Stroke (PROSCIS-B).
Sperber PS; Siegerink B; Huo S; Rohmann JL; Piper SK; Prüss H; Heuschmann PU; Endres M; Liman TG
Stroke; 2019 Nov; 50(11):3213-3219. PubMed ID: 31526121
[TBL] [Abstract][Full Text] [Related]
15. Selective Impairment of Spatial Cognition Caused by Autoantibodies to the N-Methyl-D-Aspartate Receptor.
Chang EH; Volpe BT; Mackay M; Aranow C; Watson P; Kowal C; Storbeck J; Mattis P; Berlin R; Chen H; Mader S; Huerta TS; Huerta PT; Diamond B
EBioMedicine; 2015 Jul; 2(7):755-64. PubMed ID: 26286205
[TBL] [Abstract][Full Text] [Related]
16. NMDAR1 autoantibodies amplify behavioral phenotypes of genetic white matter inflammation: a mild encephalitis model with neuropsychiatric relevance.
Arinrad S; Wilke JBH; Seelbach A; Doeren J; Hindermann M; Butt UJ; Steixner-Kumar AA; Spieth L; Ronnenberg A; Pan H; Berghoff SA; Hollmann M; Lühder F; Nave KA; Bechter K; Ehrenreich H
Mol Psychiatry; 2022 Dec; 27(12):4974-4983. PubMed ID: 34866134
[TBL] [Abstract][Full Text] [Related]
17. Exploratory investigation on antibodies to GluN1 and cognitive dysfunction in patients with chronic autoimmune psychosis.
Abe K; Chiba Y; Katsuse O; Takahashi Y; Suda A; Hattori S; Yoshimi R; Kirino Y; Kunii M; Yoshimi A; Asami T; Hishimoto A
Neurosci Lett; 2021 Jan; 743():135588. PubMed ID: 33359543
[TBL] [Abstract][Full Text] [Related]
18. Human lupus autoantibodies against NMDA receptors mediate cognitive impairment.
Kowal C; Degiorgio LA; Lee JY; Edgar MA; Huerta PT; Volpe BT; Diamond B
Proc Natl Acad Sci U S A; 2006 Dec; 103(52):19854-9. PubMed ID: 17170137
[TBL] [Abstract][Full Text] [Related]
19. Anti-NR2 antibodies, blood-brain barrier, and cognitive dysfunction.
Gulati G; Iffland PH; Janigro D; Zhang B; Luggen ME
Clin Rheumatol; 2016 Dec; 35(12):2989-2997. PubMed ID: 27357716
[TBL] [Abstract][Full Text] [Related]
20. Neuropsychiatric disease relevance of circulating anti-NMDA receptor autoantibodies depends on blood-brain barrier integrity.
Hammer C; Stepniak B; Schneider A; Papiol S; Tantra M; Begemann M; Sirén AL; Pardo LA; Sperling S; Mohd Jofrry S; Gurvich A; Jensen N; Ostmeier K; Lühder F; Probst C; Martens H; Gillis M; Saher G; Assogna F; Spalletta G; Stöcker W; Schulz TF; Nave KA; Ehrenreich H
Mol Psychiatry; 2014 Oct; 19(10):1143-9. PubMed ID: 23999527
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
